NCT07004634

Brief Summary

This RCT compares three drainage approaches after minimally invasive esophagectomy (chest tube + thoracic mediastinal drainage tube, thoracic, and abdominal mediastinal drainage tube) to evaluate perioperative outcomes, addressing current evidence gaps in pain and complication profiles.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
Last Updated

June 10, 2025

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

May 5, 2025

Last Update Submit

June 5, 2025

Conditions

Keywords

Esophageal cancerMediastinal drainage tubePostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain Scores

    Pain scores were assessed based on the visual analog scale according to the World Health Organization guidelines, in which 0 indicated no pain and 10 indicated the worst possible pain. We also recorded and evaluated maximum daily pain scores when pain caused by the mediastinal drainage tube incision.

    Pain scores were recorded at different times during the postoperative period when the patients were quiet and active (at 7 AM, 11 AM, 3 PM, and 7 PM) from postoperative day 1 to postoperative day 4.

Secondary Outcomes (1)

  • Postoperative complications

    Postoperative complications from posoperative day 1 to postoperative month 3

Study Arms (3)

Abdominal mediastinal tube

EXPERIMENTAL

Transperitoneal mediastinal drainage was performed for postoperative management of the patient.

Procedure: Abdominal mediastinal tube

Chest mediastinal tube

EXPERIMENTAL

Transthoracic mediastinal drainage was performed for postoperative management of the patient.

Procedure: Chest mediastinal tube

Chest tube + chest mediastinal tube

EXPERIMENTAL

Chest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.

Procedure: Chest tube + chest mediastinal tube

Interventions

Transthoracic mediastinal drainage was performed for postoperative management of the patient.

Chest mediastinal tube

Transperitoneal mediastinal drainage was performed for postoperative management of the patient.

Abdominal mediastinal tube

Chest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.

Chest tube + chest mediastinal tube

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Pathologically confirmed esophageal cancer requiring three-incision esophagectomy (cervical, thoracic, and abdominal incisions)
  • ASA physical status class I-III

You may not qualify if:

  • History of chronic pain or long-term use of analgesics prior to surgery
  • Severe cardiopulmonary dysfunction (e.g., FEV1 \<50%)
  • Coagulation disorders or patients undergoing reoperation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

RECRUITING

MeSH Terms

Conditions

Esophageal NeoplasmsPain, Postoperative

Interventions

Chest Tubes

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Surgical EquipmentEquipment and Supplies

Study Officials

  • Hecheng Li, PhD, MD

    Ruijin Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hecheng Li, PhD, MD

CONTACT

Wangyang Meng, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2025

First Posted

June 4, 2025

Study Start

April 30, 2025

Primary Completion

May 1, 2026

Study Completion

August 1, 2026

Last Updated

June 10, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified baseline characteristics, outcomes, and adverse events.

Locations